The global respiratory inhaler market was valued at US$ 27,779.9 million in 2017, and is expected to register a CAGR of over 4%. Increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease and increasing in air pollution due to rapid urbanization and industrialization are factors driving the growth of global respiratory inhaler market over the forecast period.

Market analysis by product type:

On the basis of product type segmentation, metered dose inhalers is expected to account for significantly higher revenue contribution

Market analysis by application:

Among all the application segments, chronic obstructive pulmonary disease segment is expected to register highest CAGR of over 4.5%

Market analysis by technology:

Among all the application segments, manual segment is expected to account for significantly higher revenue contribution

Market analysis by region:

North America market is expected to dominate the global respiratory inhaler market, and it accounts for largest market revenue over US$ 9,498.6million in 2017

Global Prefilled Syringes Market Competitive analysis:

AstraZeneca Plc, Beximco Pharmaceuticals Ltd, Boehringer Ingelheim GmbH, Cipla Ltd, GlaxoSmithKline Plc, Koninklijke Philips N.V, Merck & Co. Inc, Teva Pharmaceutical Industries Ltd, Omron Healthcare Europe B.V, PARI Medical Holding, H&T PRESSPART.

Source of Infographics:  Respiratory Inhaler Market Infographics by MarketResearch